Oxagen Limited, a biopharmaceutical company, provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases. Oxagen Limited was founded in 1997 and is based in Abingdon, the United Kingdom.
Funding Rounds (1) - $26.7MUpdate
Current Team (4)Update
Board Members and Advisors (3)Update
|Mar 30, 2015||PRNewswire UK All - Immunocore Appoints Professor Sir John Bell to its Board of Directors|
|Nov 25, 2009||Fierce Biotech - Oxagen raises 26700000 in venture round|
91 Milton Park
Abingdon, OX14 4RY